Table 1.
EV Content | Donor Cell | Recipient Cell | Function | References |
---|---|---|---|---|
Tumour initiation | ||||
miR-122 | Normal cells | T-ICs | Inhibit tumour initiation and maintains homeostasis | [134] |
IGF1 | T-ICs | Normal cells | Prevents miR-122 production leading to tumour initiation | [134] |
mir-584, miR-517c, miR-378, miR-520f, miR-142-5p miR-451, miR-518d, miR-215, miR-376a, miR-133b, miR-367 | HCC cells | Normal cells | Modulate the expression of TGF-B-activated kinase 1 and associated signalling molecules resulting in transformation of recipient cells | [135] |
miR-429 | T-ICs | Normal cells | Induces liver T-ICs properties on normal cells and thus facilitates HCC formation via RBPP4/E2F1/OCT4 axis | [136] |
Tumour growth | ||||
TUC339 | HCC cells | HCC cells | Enhance proliferation | [137] |
Angiogenesis | ||||
lncRNA H19 | Hepatoma cells | Endothelial cells | Increase the VEGF production | [139] |
miR-210-3p | HCC cells | Endothelial cells | Promotes the in vivo tubulogenesis of endothelial cells and the in vivo angiogenesis of HCC by inhibiting the expression of SMAD4 and signal transducer and activator of transcription in endothelial cells | [140] |
Vasorin | HCC cells | Endothelial cells | Accelerates the migration of endothelial cells | [141] |
Unknown | HCC cells | HUVEC cells | Potentiates tumour angiogenesis via tube formation of HUVEC cells and growth of vessels by plugs assays on nude mice | [142] |
Delta-like ligand 4 | Endothelial cells | Endothelial cells | Promote angiogenesis by blocking the Notch signal | [143] |
Invasion | ||||
MET protein, caveolins, S100 | HCC cells | HCC cells | Recipient cells acquires migratory and invasive abilities | [144] |
CD147 | HCC cells | Fibroblast | Secretes MMP-2, a protein involved in matrix degradation | [145] |
Metastasis | ||||
miR-103 | Hepatoma cells | Endothelial cells | Inhibits the expression of VE-cadherin, p120-catenin and ZO-1 to attenuate the integrity of endothelial junctions and induce vascular leakiness | [149] |
mir-1247-3p | HCC cells | Fibroblast | Conversion of fibroblast into cancer associated fibroblasts in the lung PMN | [150] |
Innate molecules | Innate immune cells | HCC cells | Increases the metastatic potential of recipient cell | [151] |
α6β4 and α6β1 integrins | HCC cells | Fibroblasts Epithelial cells |
Dictates the fate of future metastasis | [152] |
HCC, hepatocellular carcinoma; T-ICs, tumour initiating cells; HUVEC, human umbilical vein endothelial cells; MMP-2, matrix metalloproteinase-2; lncRNA H19, long non-coding RNA H19.